Skip to content

Evaluation of Treatment for Canada Syndrome

Evaluation of Treatment for Canada Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093936
Enrollment
Unknown
Registered
2024-12-13
Start date
2024-12-31
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Canada syndrome

Interventions

Observation Group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The patient with the confirmed diagnosis of Canada syndrome.

Exclusion criteria

Exclusion criteria: Patients who were not followed up regularly;Patients with other serious medical conditions, such as heart and lung disease.

Design outcomes

Primary

MeasureTime frame
Degree of endoscopic remission;

Countries

China

Contacts

Public ContactZhu Wang

West China Hospital, Sichuan University

wangzhu@wchscu.cn+86 189 8174 5741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026